These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33621561)

  • 1. Intranasal insulin and orexins to treat age-related cognitive decline.
    Erichsen JM; Calva CB; Reagan LP; Fadel JR
    Physiol Behav; 2021 May; 234():113370. PubMed ID: 33621561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.
    Calva CB; Fadel JR
    Brain Res; 2020 Mar; 1731():145921. PubMed ID: 30148983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexins and appetite regulation.
    Rodgers RJ; Ishii Y; Halford JC; Blundell JE
    Neuropeptides; 2002 Oct; 36(5):303-25. PubMed ID: 12450737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation.
    Modi HR; Wang Q; Gd S; Sherman D; Greenwald E; Savonenko AV; Geocadin RG; Thakor NV
    PLoS One; 2017; 12(9):e0182707. PubMed ID: 28957432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexins/hypocretins: pain regulation and cellular actions.
    Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
    Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice.
    Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Yanai K
    Peptides; 2005 May; 26(5):767-77. PubMed ID: 15808907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes.
    Nowak KW; Strowski MZ; Switonska MM; Kaczmarek P; Singh V; Fabis M; Mackowiak P; Nowak M; Malendowicz LK
    Int J Mol Med; 2005 Jun; 15(6):969-72. PubMed ID: 15870901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).
    Calva CB; Fayyaz H; Fadel JR
    J Neurochem; 2018 May; 145(3):232-244. PubMed ID: 29250792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.
    Deadwyler SA; Porrino L; Siegel JM; Hampson RE
    J Neurosci; 2007 Dec; 27(52):14239-47. PubMed ID: 18160631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides controlling energy balance: orexins and neuromedins.
    Nixon JP; Kotz CM; Novak CM; Billington CJ; Teske JA
    Handb Exp Pharmacol; 2012; (209):77-109. PubMed ID: 22249811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs to interfere with orexins (hypocretins).
    Selbach O; Eriksson KS; Haas HL
    Drug News Perspect; 2003 Dec; 16(10):669-81. PubMed ID: 14747847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin/hypocretin role in reward: implications for opioid and other addictions.
    Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
    Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexins/hypocretins excite basal forebrain cholinergic neurones.
    Eggermann E; Serafin M; Bayer L; Machard D; Saint-Mleux B; Jones BE; Mühlethaler M
    Neuroscience; 2001; 108(2):177-81. PubMed ID: 11734353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexins and adipoinsular axis function in the rat.
    Switońska MM; Kaczmarek P; Malendowicz LK; Nowak KW
    Regul Pept; 2002 Mar; 104(1-3):69-73. PubMed ID: 11830279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies.
    Nowak KW; Maćkowiak P; Switońska MM; Fabiś M; Malendowicz LK
    Life Sci; 2000; 66(5):449-54. PubMed ID: 10670833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexins: tissue localization, functions, and its relation to insulin secretion and diabetes mellitus.
    Adeghate E
    Vitam Horm; 2012; 89():111-33. PubMed ID: 22640611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis.
    Rouet-Benzineb P; Rouyer-Fessard C; Jarry A; Avondo V; Pouzet C; Yanagisawa M; Laboisse C; Laburthe M; Voisin T
    J Biol Chem; 2004 Oct; 279(44):45875-86. PubMed ID: 15310763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides.
    Holmqvist T; Akerman KE; Kukkonen JP
    Neurosci Lett; 2001 Jun; 305(3):177-80. PubMed ID: 11403934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats.
    Kis GK; Molnár AH; Daruka L; Gardi J; Rákosi K; László F; László FA; Varga C
    Pflugers Arch; 2012 Apr; 463(4):531-6. PubMed ID: 22350729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of orexins in regulation of feeding and wakefulness.
    Sakurai T
    Neuroreport; 2002 Jun; 13(8):987-95. PubMed ID: 12060794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.